...
blco-img

Bausch + Lomb Corp, Common Stock

BLCO

NYQ

$18

+$0.05

(0.28%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.48B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
398.57K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$13.16 L
$21.69 H
$18

About Bausch + Lomb Corp, Common Stock

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameBLCOSectorS&P500
1-Week Return-3.23%-2.12%-3%
1-Month Return-7.12%-3.42%-0.73%
3-Month Return-9.82%-11.13%2.87%
6-Month Return19.28%-5.74%7.17%
1-Year Return17.57%3.97%25.31%
3-Year Return-1.05%28.38%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.78B3.41B3.77B3.77B4.15B[{"date":"2019-12-31","value":91.12,"profit":true},{"date":"2020-12-31","value":82.3,"profit":true},{"date":"2021-12-31","value":90.81,"profit":true},{"date":"2022-12-31","value":90.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.33B1.28B1.47B1.52B1.64B[{"date":"2019-12-31","value":80.82,"profit":true},{"date":"2020-12-31","value":78.26,"profit":true},{"date":"2021-12-31","value":89.34,"profit":true},{"date":"2022-12-31","value":92.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit2.45B2.13B2.30B2.25B2.50B[{"date":"2019-12-31","value":97.88,"profit":true},{"date":"2020-12-31","value":84.94,"profit":true},{"date":"2021-12-31","value":91.77,"profit":true},{"date":"2022-12-31","value":89.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin64.88%62.34%61.04%59.69%60.40%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":96.09,"profit":true},{"date":"2021-12-31","value":94.08,"profit":true},{"date":"2022-12-31","value":92,"profit":true},{"date":"2023-12-31","value":93.09,"profit":true}]
Operating Expenses1.99B1.83B1.95B2.03B2.37B[{"date":"2019-12-31","value":83.74,"profit":true},{"date":"2020-12-31","value":77.04,"profit":true},{"date":"2021-12-31","value":82.22,"profit":true},{"date":"2022-12-31","value":85.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income532.00M260.00M329.00M207.00M130.00M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":48.87,"profit":true},{"date":"2021-12-31","value":61.84,"profit":true},{"date":"2022-12-31","value":38.91,"profit":true},{"date":"2023-12-31","value":24.44,"profit":true}]
Total Non-Operating Income/Expense(132.00M)33.00M(10.00M)(274.00M)(564.00M)[{"date":"2019-12-31","value":-400,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-30.3,"profit":false},{"date":"2022-12-31","value":-830.3,"profit":false},{"date":"2023-12-31","value":-1709.09,"profit":false}]
Pre-Tax Income399.00M290.00M318.00M73.00M(166.00M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":72.68,"profit":true},{"date":"2021-12-31","value":79.7,"profit":true},{"date":"2022-12-31","value":18.3,"profit":true},{"date":"2023-12-31","value":-41.6,"profit":false}]
Income Taxes96.00M307.00M125.00M58.00M82.00M[{"date":"2019-12-31","value":31.27,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":40.72,"profit":true},{"date":"2022-12-31","value":18.89,"profit":true},{"date":"2023-12-31","value":26.71,"profit":true}]
Income After Taxes303.00M(17.00M)193.00M15.00M(248.00M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-5.61,"profit":false},{"date":"2021-12-31","value":63.7,"profit":true},{"date":"2022-12-31","value":4.95,"profit":true},{"date":"2023-12-31","value":-81.85,"profit":false}]
Income From Continuous Operations303.00M(17.00M)193.00M15.00M(248.00M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-5.61,"profit":false},{"date":"2021-12-31","value":63.7,"profit":true},{"date":"2022-12-31","value":4.95,"profit":true},{"date":"2023-12-31","value":-81.85,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income298.00M(17.00M)182.00M15.00M(260.00M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-5.7,"profit":false},{"date":"2021-12-31","value":61.07,"profit":true},{"date":"2022-12-31","value":5.03,"profit":true},{"date":"2023-12-31","value":-87.25,"profit":false}]
EPS (Diluted)--(0.60)0.980.74[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-61.22,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.51,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BLCO
Cash Ratio 0.18
Current Ratio 1.57
Quick Ratio 0.95

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BLCO
ROA (LTM) 0.89%
ROE (LTM) -5.23%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BLCO
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BLCO
Trailing PE NM
Forward PE 15.27
P/S (TTM) 1.35
P/B 0.96
Price/FCF 67
EV/R 2.28
EV/Ebitda 18.91
PEG 0.70

FAQs

What is Bausch + Lomb Corp share price today?

Bausch + Lomb Corp (BLCO) share price today is $18

Can Indians buy Bausch + Lomb Corp shares?

Yes, Indians can buy shares of Bausch + Lomb Corp (BLCO) on Vested. To buy Bausch + Lomb Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BLCO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bausch + Lomb Corp be purchased?

Yes, you can purchase fractional shares of Bausch + Lomb Corp (BLCO) via the Vested app. You can start investing in Bausch + Lomb Corp (BLCO) with a minimum investment of $1.

How to invest in Bausch + Lomb Corp shares from India?

You can invest in shares of Bausch + Lomb Corp (BLCO) via Vested in three simple steps:

  • Click on Sign Up or Invest in BLCO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bausch + Lomb Corp shares
What is Bausch + Lomb Corp 52-week high and low stock price?

The 52-week high price of Bausch + Lomb Corp (BLCO) is $21.69. The 52-week low price of Bausch + Lomb Corp (BLCO) is $13.16.

What is Bausch + Lomb Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bausch + Lomb Corp (BLCO) is

What is Bausch + Lomb Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bausch + Lomb Corp (BLCO) is 0.96

What is Bausch + Lomb Corp dividend yield?

The dividend yield of Bausch + Lomb Corp (BLCO) is 0.00%

What is the Market Cap of Bausch + Lomb Corp?

The market capitalization of Bausch + Lomb Corp (BLCO) is $6.48B

What is Bausch + Lomb Corp’s stock symbol?

The stock symbol (or ticker) of Bausch + Lomb Corp is BLCO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top